Rectal Cancer
A Phase II Study Investigating Fruquintinib plus FOLFIRI as Second-Line Treatment for Participants with Metastatic Colorectal Cancer (mCRC)
- Details
ClinicalTrials.gov ID:
NCT07011576
Diagnosis Type:
NA
USOR Number:
- Address
,
P: